Ocugen is trading at MXN 16.96, with a change of -10.74% on October 9, 2026; no confirmed company-specific news directly explains the decline. - Ocugen is scheduled to present OCU410 Phase 2 ArMaDa results at the AAO meeting at 5:05 p.m. CST, after the reported 1:45 p.m. update; the announcement reports no results and does not link them to the stock move. - Sector and major-index context is positive and does not clearly explain the decline; trading volume data was not provided.